Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA methylation is an epigenetic modification involving the addition of a methyl group to DNA, typically at cytosine residues. This process plays crucial roles in gene regulation, development, and disease. It is catalyzed by DNA methyltransferases (DNMTs) and can be reversed by demethylation pathways. Aberrant DNA methylation patterns are associated with various diseases, making it a target for epigenetic therapies.
Targeting DNA methyltransferases (DNMTs) to alter methylation patterns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Methylation (DNAm).